Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
Feature|Videos|January 9, 2025

An All-Government Approach: Recognizing the Benefits and Drawbacks

The panel covers the benefits and challenges of a unified government pandemic response, focusing on transparency and trust-building.

In this segment, the panelists talk about the good and bad of a coordinated government response to pandemics. The importance of transparency, unified communication, and addressing public skepticism is emphasized, as well as strategies to improve vaccine uptake and trust.


Related to this article

The BioPharm Brief: A First for Streamlined Biosimilar Approval, a Head-to-Head Bispecific Trial in Wet AMD, and In Vivo KIR-CAR T
Biocon’s pertuzumab biosimilar Pebrilzo becomes the first biosimilar approved under EMA’s tailored clinical approach, Visara doses the first patient in a phase 2b trial comparing its VEGF-A/ANG-2 bispecific VIS-101 with aflibercept in wet AMD, and Verismo Therapeutics licenses Stanford’s PACK-IT technology for in vivo KIR-CAR T therapies.